This Week in ResearchHome »
March 6 - 12, 2023
Protein S-Nitrosylation of Viral Proteins as a Common Antiviral Response for cGAS/STING Pathway and Uncovering Metabolic Determinants of HIV-1 Latency Reversal in the Myeloid Cellular Reservoir
Low-cost, portable optical coherence tomography for point of care use
Making Upstate Medical University an Intellectual Property Powerhouse and the Team Who Supports You
Click here to register
The Industry and External Affairs (I&EA) Team serves as your technology transfer and commercialization support system. The team is focused on enabling Upstate Medical University to be the best place for innovators and entrepreneurs to solve the world’s most pressing problems. The I&EA team consists of technology and business development experts, entrepreneurs, investors, patent attorneys and agents, and marketing gurus, and more generally, a group of innovative and inquisitive problem-solvers. The team is motivated by the privilege and opportunity to serve the Upstate Medical University research community. Nothing gives the team us more pleasure than “geeking out” with innovators to learn about their research and collaborating to implement a strategy to translate into a product or service that will transform lives.
This presentation will provide an overview of all the resources and support services the I&EA team provides, including all aspects technology transfer lifecycle and new venture support services. Geek out with us on March 8th for a lively conversation focused on the following:
- What to do when you have developed new intellectual property;
- How to engage with the team to assess patentability on a new discovery;
- What happens if your intellectual property is valuable, but not patentable;
- How to disclose intellectual property;
- How our sophisticated experts in patents, commercialization, marketing and new ventures work with and for you to move your discoveries to outside-world impact;
- Receive an overview of the SUNY Technology Accelerator Fund (TAF) Program, SUNY Startup Summer School and other opportunities.
There will be plenty of time for Q&A, so please bring questions!
Dr. Vyas’ lab has a longstanding interest in the innate immune response to fungal pathogens. In addition to running an NIH-funded laboratory, he serves as the tenth Program Director of the Massachusetts General Hospital Department of Medicine Residency Program. In this capacity, he currently supervises 207 interns and residents. He has implemented two programs that enable residents to spend a year dedicated to research through NIAID (R25 MGH Next-Gen PSTP) with focus on infectious diseases and transplant immunology as well as NHLBI (R38 MGH Next-Gen StARR) with a focus on pulmonary and cardiovascular disease. As an NIH-funded investigator with interests in basic science, he provides a unique perspective to the medical house staff. Outstanding clinical care is fueled by basic discovery and the greatest opportunities to improve patient care come from high-quality research. To this end, he is uniquely qualified to serve as a PD/PI for this R38 grant application. His administrative expertise and focus on career development complement his Co-Program Directors, Dr. Christine Ritchie (Medicine) and Dr. Bradley Hyman (Neurology), who are leaders in aging-related research.